Cmh Wealth Management LLC Amgen Inc Transaction History

Cmh Wealth Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 11, 2018	SELL	$169.43 - $198.0 $1.88 Million - $2.19 Million	-11,083 Closed	0 $0
Q4 2017 Jan 12, 2018	SELL	$168.79 - $188.59 $188,200 - $210,277	-1,115 Reduced 9.14%	11,083 $1.96 Million
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $2.04 Million - $2.33 Million	12,198	12,198 $2.28 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Cmh Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Cmh Wealth Management LLC with notifications on news.